Novel resveratrol analogs induce apoptosis and cause cell cycle arrest in HT29 human colon cancer cells: Inhibition of ribonucleotide reductase activity
Walter Jaeger(University of Vienna), Philipp Saiko(Ludwig Boltzmann Institute Applied Diagnostics), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Michael Grusch(Comprehensive Cancer Center Vienna), Thomas Erker(University of Vienna), Michael Pemberger(Medical University of Vienna), Norbert Handler(University of Vienna), Thomas Szekeres(Medical University of Vienna), Monika Fritzer‐Szekeres(Vienna General Hospital), Ivo Savinc(Medical University of Vienna)
Cited by 40
Related Papers
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
|PLoS ONE|2011|437
Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice
|Science|2018|422
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
|Annals of Oncology|2013|403
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
|Nature Medicine|2022|395
Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure–activity relationship
|Biochemical Pharmacology|2005|303